Delivery Order SPE2DB25D3110-SPE2DB25FTEGF
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for Dapagliflozin 10 mg tablets (30-count packaging) with a ceiling value of $91,388.22. This firm fixed-price contract, which carries an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation by the Defense Logistics Agency (DLA), a defense-focused federal procurement entity. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order contract valued at $2,132.04 by the Defense Logistics Agency (DLA) on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract calls for the delivery of Dapagliflozin 10 mg tablets in a 30-count package, a generic diabetes medication. This delivery order operates under a firm fixed-price structure with no set-aside designation, indicating...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
- The Defense Logistics Agency awarded a $3,885.35 delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count) on September 9, 2025, with completion expected by September 10, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a small-value transaction typical of pharmaceutical procurement under AmerisourceBergen's broader federal contract portfolio, which emphasizes...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,941,013 units of Dapagliflozin 10 mg tablets, a prescription medication. The order has a ceiling value of $3,969.09 and a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count packages) with a ceiling value of $1,376.58 under a firm fixed-price contract. This delivery order represents a pediatric/routine pharmaceutical procurement with an ultimate completion date of August 12, 2025. The contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,756.65 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30, with a contract value of $1,008.03 and a firm fixed price structure. This non-set-aside competitive award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $56,588.09 firm fixed price delivery order from the Defense Logistics Agency on May 30, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30. This non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is...
- This is a $13,303.49 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,504,602 dapagliflozin 10 mg tablets. The order has an ultimate completion date of August 20, 2024 and is not set aside. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide range...